TrumpRx launches with roughly 40 medications

The White House launched TrumpRx, a drug-buying website listing roughly 40 medicines with discounted direct-to-consumer prices. The site mainly targets uninsured or self-pay patients and includes products from five manufacturers.

The White House launched a drug-buying website called TrumpRx on Thursday. The site opened with roughly 40 medicines, including obesity treatments Wegovy and Zepbound and the infertility drug Gonal-F. TrumpRx offers discounted direct-to-consumer purchases or coupons to be used at certain pharmacies. The administration presented the site as part of broader efforts to lower prescription costs. Key details: - The site debuted with about 40 drugs and lists products from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer. - Customers can purchase through a manufacturer's direct-to-consumer site or obtain coupons that can be presented at some pharmacies. - The lowest dose of Eli Lilly's Zepbound is listed on the site at $299 per month, about $50 below the company's prior cash price and roughly $700 below list price, per 46brooklyn Research. - Several medicines announced in earlier negotiations, such as Amgen's Repatha and Gilead's Epclusa, were not yet available on the site. - Pfizer said it will make more than 30 medicines available at discounts averaging about 50% and up to 85% off list prices for uninsured or self-pay patients. - Analysts and policy experts note the site primarily serves the self-pay market; most insured Americans typically obtain lower net prices through coverage and rebates. Summary: The launch creates a channel for discounted direct purchases that may help uninsured and self-pay patients while having limited immediate effect on most insured consumers. The administration said more drugs would be added and is seeking legislation to establish "most favored nation" pricing, though passage in Congress is described as uncertain.